News & Analysis on Clinical Trial Services & Contract Research And Development
By Melissa Fassbender
- Last updated on
BioAscent Discovery has appointed two directors of chemistry and biosciences to oversee the development and delivery of the company’s drug discovery services.
Among the new hires includes, Angus Morrison, PhD, director of chemistry, who told us, “Having worked in pre-clinical drug discovery for the past 15 years, most recently leading the medicinal chemistry efforts of the European Lead Factory project, I have been very fortunate to work with some outstanding collaborators helping them to translate their innovative drug discovery projects into tangible assets for further investment and progression.”
“In joining BioAscent, I aim to continue this, working in close collaboration with our clients to bring excellence in drug design and with a thorough understanding of the challenges and pitfalls that are frequently encountered along the discovery axis. The outstanding facilities and team here are second to none and will allow us to truly make a difference not only to our clients but ultimately for patient benefit,” Morrison said.